ArticleBlood research2020

Safety and efficacy analysis of ibrutinib in 32 patients with CLL and various B-cell lymphomas: real-world data from a single-center study in Turkey.

Mesut Göçer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.